|
N-(1,3-Dihydro-1,3-dioxoisobenzofuran-4-yl)acetamide;AcetaMide, N-(1,3-dihydro-1,3-dioxo-4-isobenzofuranyl)-;3-AcetylaMino-phthalsaeure-anhydrid;3-AcetaMidophthalic anhydride;1,3-Dioxo-2-isoindolineaceticacid CAS:6296-53-3;3-AcetylaMinophthalic Anhydride;N-(1,3-Dioxo-1,3-dihydro-2-benzofuran-4-yl)acetaMide;NSC 16261 |
N-(1,3-ジヒドロ-1,3-ジオキソイソベンゾフラン-4-イル)アセトアミド |
6296-53-3 |
C10H7NO4 |
|
|
|
ledipasvir interMediate;(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benziMidazol-2-yl]-, 1,1-diMethylethyl ester, (1R,3S,4S)-;(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester;(1R,3S,4S)-2-tert-butyl-3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[D]iMidazol-2-yl)-2-azabicyclo[2.2.1]hept |
|
1256387-87-7 |
C7H11NO2 |
|
|
|
(3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid;(1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid;2-Azabicyclo[2.2.1]heptane-2,3-dicarboxylic acid, 2-(1,1-diMethylethyl) ester, (1R,3S,4S)-;(1R,3S,4S)-N-(Tert-butoxycarbonyl)-2-azabicyclo-[2.2.1]-heptane-3-carboxylic acid;(1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid 97% |
|
291775-59-2 |
C12H19NO4 |
|
|
|
RAMAGE LINKER;RAMAGE LINKER FMOC-SUBEROL;(R,S)-2-[[5-(9-FLUORENYLMETHYLOXYCARBONYLAMINO)-DIBENZO[A,D]CYCLOHEPTANE-2-YL]OXY]-ACETIC ACID;5-FMOC-AMINO-10, 11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE-2-HYDROXY ACETIC ACID;FMOC-SUBEROL;RAMAGE LINKER, FMOC-SUBEROL, 2-{[(R,S)-5-(9-FLUORENYLMETHYLOXYCARBONYL-AMINO)-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE-2-YL]OXY} ACETIC ACID;2-{[(R,S)-5-(9-Fluorenylmethyloxycarbonyl-amino)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene-2-yl]oxy}acetic acid;Fmoc-Suberol, (R,S)-2-{[5-(9-Fluorenylmethyloxycarbonylamino)-dibenzo[a,d]cycloheptane-2-yl]oxy}-acetic acid |
|
212783-75-0 |
C32H27NO5 |
|
|
|